The first Russian experience with the endothelin 1 receptor inhibitor traclir used in patients with pulmonary hypertension associated with systemic connective tissue diseases

The first Russian experience with the endothelin 1 receptor inhibitor traclir used in patients with pulmonary hypertension associated with systemic connective tissue diseases

Objective: to study the efficacy and safety of the endothelin 1 receptor inhibitor traclir in patients with pulmonary hypertension (PH) asso ciated with systemic connective tissue diseases. Subjects and methods. The study include...

Full description

Bibliographic Details
Main Authors: Aleksandr Vitalyevich Volkov, T V Martynyuk, N N Yudkina, N M Danilov, T M Reshetnyak, I E Chazova, E L Nasonov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2011-12-01
Series:Научно-практическая ревматология
Subjects:
pulmonary hypertension
scleroderma systematica
exanthematous lupus erythematosus
right heart catheterization
6-minute walk test
Online Access:https://rsp.mediar-press.net/rsp/article/view/653

Internet

https://rsp.mediar-press.net/rsp/article/view/653

Similar Items